|
Market Closed -
OTC Markets
12:57:58 04/06/26 am AEST
|
5-day change | 1st Jan Change | ||
| 0.1052 USD | -2.09% |
|
-31.18% | -87.61% |
| 14/08 | CASI Pharmaceuticals, Inc. Reports Earnings Results for the Half Year Ended June 30, 2026 | CI |
| 14/08 | Casi Pharmaceuticals, Inc. Announces Management Changes | CI |
| Market Cap | 2.65M 2.29M 2.16M 1.96M 3.68M 253M 3.71M 25.82M 9.94M 129M 9.94M 9.72M 409M | P/E 2024 |
-1.11x | P/E 2025 | -0.33x |
|---|---|---|---|---|---|
| Enterprise Value | 24.5M 21.21M 20.02M 18.15M 34.05M 2.34B 34.32M 239M 91.97M 1.19B 92.02M 89.98M 3.78B | EV / Sales 2024 |
1.75x | EV / Sales 2025 | 1.9x |
| Free-Float |
53.62% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | -2.09% | ||
| 1 week | -31.18% | ||
| Current month | -18.25% | ||
| 1 month | -27.86% | ||
| 3 months | -47.35% | ||
| 6 months | -27.38% | ||
| Current year | -87.61% |
| 1 week | 0.11 |  | 0.14 |
| 1 month | 0.11 | | 0.16 |
| Current year | 0.05 | | 1.2 |
| 1 year | 0.05 | | 2.28 |
| 3 years | 0.05 | | 8.48 |
| 5 years | 0.05 | | 15.7 |
| 10 years | 0.05 | | 88.92 |
| Manager | Title | Age | Since |
|---|---|---|---|
David Cory
CEO | Chief Executive Officer | 62 | 21/07/2025 |
Kun Qian
DFI | Director of Finance/CFO | 44 | 16/05/2025 |
Chun Hua Wang
COO | Chief Operating Officer | 54 | 01/01/2017 |
| Director | Title | Age | Since |
|---|---|---|---|
Yue Wu
BRD | Director/Board Member | 62 | 01/04/2013 |
Zhen Bo Su
BRD | Director/Board Member | 50 | 21/03/2023 |
Thomas Folinsbee
BRD | Director/Board Member | 59 | 21/03/2023 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 18/3/26 | Emerging Technology Partners LLC
| Other | Company | 1,097,341 | 7.0830% | |
| 18/3/26 | Panacea Venture
| Other | Company | 4,529,956 | 29.2393% | |
| 18/3/26 | Other | Chief Financial Officer | 75,000 | 0.4841% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -2.09% | -31.18% | -95.38% | -94.99% | 2.88M | |
| +2.02% | -0.96% | +50.69% | +90.07% | 994B | |
| +0.28% | -3.24% | +49.57% | +62.40% | 640B | |
| +1.81% | +2.07% | +19.89% | +73.17% | 454B | |
| +5.00% | +1.23% | +36.64% | +40.84% | 337B | |
| +1.68% | -12.09% | +15.25% | +26.83% | 261B | |
| +3.81% | +1.23% | +3.05% | +14.86% | 246B | |
| +1.10% | -12.75% | +38.03% | +48.31% | 204B | |
| +1.43% | -6.19% | -19.49% | -58.38% | 190B | |
| +1.87% | -3.04% | +27.81% | +89.38% | 178B | |
| Average | +1.19% | -5.18% | +12.60% | +29.25% | 350.48B | |
| Weighted average by Cap. | +1.04% | -4.42% | +33.46% | +57.60% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 28.54M 24.71M 23.32M 21.14M 39.66M 2.73B 39.98M 278M 107M 1.39B 107M 105M 4.4B | 20.71M 17.93M 16.93M 15.34M 28.79M 1.98B 29.02M 202M 77.75M 1.01B 77.79M 76.07M 3.2B |
| Net income | -39.26M -33.99M -32.08M -29.08M -54.56M -3.75B -55M -383M -147M -1.91B -147M -144M -6.06B | -48.06M -41.61M -39.27M -35.6M -66.79M -4.59B -67.32M -469M -180M -2.34B -180M -176M -7.42B |
| Net Debt | 6.05M 5.24M 4.94M 4.48M 8.41M 578M 8.48M 59M 22.71M 294M 22.72M 22.22M 934M | 21.85M 18.92M 17.86M 16.19M 30.37M 2.09B 30.62M 213M 82.04M 1.06B 82.07M 80.26M 3.37B |
Employees
214
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 14/09/26 | USD 0.1288 | -7.99% | 2,453 |
| 10/09/26 | USD 0.1400 | +8.69% | 3,015 |
| 09/09/26 | USD 0.1288 | -4.59% | 6,342 |
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- CASIF Stock
Select your edition
All financial news and data tailored to specific country editions
